Regenxbio (RGNX) Shares Outstanding (Diluted) (2016 - 2026)
Regenxbio (RGNX) reported Shares Outstanding (Diluted) of 53.02 million for Q2 2026, up 3.0% from 51.48 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends
For FY2025, Regenxbio posted Shares Outstanding (Diluted) of 51.57 million, up 4.2% from FY2024.
- Shares Outstanding (Diluted) has increased for three consecutive years, with a five-year compound annual growth rate of 6.7% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 49.51 million in FY2024 (+13.2%), 43.73 million in FY2023 (+1.3%), 43.15 million in FY2022 (-1.7%) and 43.91 million in FY2021 (+17.8%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2016.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q4 2021 (growth of 17.8%); the low point was Q4 2022 (a decline of 1.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - | 53.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.02 Mn |
| Dec 31, 2025 | 51.57 Mn |
| Sep 30, 2025 | 51.69 Mn |
| Jun 30, 2025 | 51.48 Mn |
| Mar 31, 2025 | 51.43 Mn |
| Dec 31, 2024 | 49.51 Mn |
| Sep 30, 2024 | 50.80 Mn |
| Jun 30, 2024 | 50.60 Mn |
| Mar 31, 2024 | 45.73 Mn |
| Dec 31, 2023 | 43.73 Mn |
| Sep 30, 2023 | 43.95 Mn |
| Jun 30, 2023 | 43.53 Mn |
| Mar 31, 2023 | 43.45 Mn |
| Dec 31, 2022 | 43.15 Mn |
| Sep 30, 2022 | 43.25 Mn |
| Jun 30, 2022 | 43.11 Mn |
| Mar 31, 2022 | 42.94 Mn |
| Dec 31, 2021 | 43.91 Mn |
| Sep 30, 2021 | 42.63 Mn |
| Jun 30, 2021 | 42.51 Mn |
API Access
Regenxbio Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();